| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/11/2000 | CA1340950C Process and agents for phosphorylation |
| 04/06/2000 | WO2000018967A1 A method for analyzing polynucleotides |
| 04/06/2000 | WO2000018792A1 Solid phase synthesis, whereby the solid phase consists of two different substrates |
| 04/06/2000 | WO2000018787A1 Gene mutated in wolfram syndrome |
| 04/06/2000 | WO2000018781A1 Antisense modulation of survivin expression |
| 04/06/2000 | WO2000018778A1 Synthesis of codon randomized nucleic acids |
| 04/06/2000 | WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 04/06/2000 | WO1999043287A3 Phosphate-based dendrimers for bioassays |
| 04/06/2000 | CA2347923A1 Solid phase synthesis with the solid phase consisting of two different substrates |
| 04/05/2000 | EP0990702A1 METHOD FOR FORMING FULL-LENGTH cDNA LIBRARY |
| 04/05/2000 | EP0990047A2 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| 04/05/2000 | EP0989991A1 Purification of oligomers |
| 04/05/2000 | EP0989990A1 Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides |
| 04/05/2000 | EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | EP0840804B1 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| 04/05/2000 | EP0733072B1 Antibody against carcinoembryonic antigen (cea) |
| 04/05/2000 | EP0568622B1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 04/05/2000 | CN1249339A Core sequence of sex-determining genes for milk cow and its application |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1050995C Elaboration of host defense mediators into biological fluids by systemic ds RNA treatment |
| 04/04/2000 | US6046319 Antisense oligodeoxynucleotides regulating expression of TNF-α |
| 04/04/2000 | US6046172 Hydrolytically processed oligodeoxyribonucleotides and their pharmaceutical compositions |
| 04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
| 04/04/2000 | US6046044 Cisplatin resistance proteins |
| 04/04/2000 | US6046011 Mammalian adrenocorticotropic hormone receptors and uses |
| 04/04/2000 | US6045996 Hybridization assays on oligonucleotide arrays |
| 04/04/2000 | US6045992 Reverse transcriptase detection and inhibition |
| 04/04/2000 | US6045798 Membrane-associated immunogens of mycobacteria |
| 04/04/2000 | US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene |
| 04/04/2000 | CA2173878C Polynucleotide for treating systemic lupus erythematosus |
| 04/04/2000 | CA2105402C Radiolabelled compound formulations |
| 03/30/2000 | WO2000017401A2 Method and apparatus for effecting and monitoring nucleic acid amplification |
| 03/30/2000 | WO2000017398A1 Parallel selex |
| 03/30/2000 | WO2000017360A1 Cystine knot growth factor mutants |
| 03/30/2000 | WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 03/30/2000 | WO2000017330A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides |
| 03/30/2000 | WO2000017320A2 Methods and reagents for inactivating ribonucleases |
| 03/30/2000 | WO2000016872A1 Methods and apparatus for processing temperature sensitive materials |
| 03/30/2000 | WO2000008196A3 Urate oxidase |
| 03/30/2000 | WO1999067427A9 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/30/2000 | WO1999055913A9 Reduced complexity nucleic acid targets and methods of using same |
| 03/30/2000 | CA2360539A1 Methods and reagents for inactivating ribonucleases |
| 03/30/2000 | CA2344288A1 Parallel selex |
| 03/30/2000 | CA2344277A1 Cystine knot growth factor mutants |
| 03/30/2000 | CA2344105A1 Dna polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides |
| 03/29/2000 | EP0989185A1 Method of cleaving specific nucleic acid sequence |
| 03/29/2000 | EP0988377A1 Zinc finger protein derivatives and methods therefor |
| 03/29/2000 | EP0988307A1 Solid-phase nucleic acid isolation |
| 03/29/2000 | EP0988047A1 Soluble ctla4 mutant molecules and uses thereof |
| 03/29/2000 | EP0988045A1 Peptide nucleic acid monomers and oligomers |
| 03/29/2000 | EP0675873A4 Synthesis of encoded polymers |
| 03/29/2000 | EP0620864B1 Process for immobilizing nucleic acid probes on polystyrene surfaces |
| 03/28/2000 | US6043353 For solid phase synthesis |
| 03/28/2000 | US6043352 Increased hybridization binding affinity and nuclease resistance |
| 03/28/2000 | US6043222 Two new human DnaJ-like proteins |
| 03/28/2000 | US6043220 Threonine-containing protegrins |
| 03/28/2000 | US6043211 Adding to a first protein a peptide analogue of a phosphorylated region, whereupon the binding of said first protein to said second protein is inhibited |
| 03/28/2000 | US6043091 Compound of 8 to 30 nucleobases targeted to coding region, 3' or 5'-untranslated region, or start codon of nucleic acid encoding a carbohydrate metabolism enzyme; for antidiabetic agents against non-insulin dependent diabetes |
| 03/28/2000 | US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction |
| 03/28/2000 | US6043070 With specific sequence of nucleotide linkages; for nucleic acid amplification reactions such as polymerase chain reactions and nucleic acid sequencing |
| 03/28/2000 | US6043060 Nucleotide analogues |
| 03/28/2000 | US6043059 Performing series of reactions involving hybridizing primer to target and effecting chain extension/chain termination; using primer from presynthesized set having raised annealing temperature and/or improved annealing properties |
| 03/28/2000 | US6043051 Nucleotide sequence capable of transcriptional control by a pleiotropic drug resistance gene product and can be used in a complete nutrient medium |
| 03/28/2000 | US6043028 Method for synthesizing single-stranded stem-loop DNA's the products and uses therefore |
| 03/28/2000 | US6042846 Resistant to nuclease hydrolysis; efficiency |
| 03/28/2000 | CA2088683C Homogenous assay system |
| 03/28/2000 | CA1340935C Fc gamma receptor |
| 03/23/2000 | WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 03/23/2000 | WO2000015651A1 Regulation of immune responses by attractin |
| 03/23/2000 | WO1999066024A9 Methods of monitoring disease states and therapies using gene expression profiles |
| 03/23/2000 | WO1999062847A3 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components |
| 03/23/2000 | WO1999061607A3 Antisense oligonucleotides for treating proliferating cells |
| 03/23/2000 | CA2641651A1 Immune activation by double-stranded polynucleotides |
| 03/23/2000 | CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 03/22/2000 | EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit |
| 03/22/2000 | EP0987336A2 Synthesis of chemical tags |
| 03/22/2000 | EP0987328A2 Bio-inorganic hybrid composite capable of storing and carrying genes and preparation thereof |
| 03/22/2000 | EP0987029A1 Use of a catonic polymer for the preparation of a complex with nucleic acid and related compositions |
| 03/22/2000 | EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 03/22/2000 | EP0986571A1 Novel sulfur transfer reagents for oligonucleotide synthesis |
| 03/22/2000 | EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals |
| 03/22/2000 | EP0789704B1 Purification of polynucleotides from polynucleotide/polysaccharide mixtures |
| 03/21/2000 | US6040439 Method for chemical synthesis of oligonucleotides |
| 03/21/2000 | US6040438 Contacting oligonucleotide of at least one phosphorous (iii) linkage with solution of solvent and thiodicarbonic acid diester polysulfide in automated dna synthesizer producing oligonucleotide with sulfurized phosphorous (v) linkage |
| 03/21/2000 | US6040423 Solid phase synthesis using one-piece support to synthesize a plurality of different peptides by spotting n-protected amino acid solution in discrete zones, coupling c-terminal to support, then coupling additional amino acids |
| 03/21/2000 | US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections |
| 03/21/2000 | US6040296 Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation |
| 03/21/2000 | US6040193 Combinatorial strategies for polymer synthesis |
| 03/21/2000 | US6040181 Regulation of bcl-2 gene expression |
| 03/21/2000 | US6040165 Mutant prenyl diphosphate synthase |
| 03/21/2000 | US6040159 Nucleotide sequence of ribonucleotides and optionally deoxyribonucleotides with optionally modified phosphates and hydrogen bonded to itself; targeted against tumor necrosis factor; for antiarthritic agents, antisense agents, viricides |
| 03/21/2000 | US6040156 Amino acid sequence of enzyme capable of transferring glucuronic acid from donor to acceptor molecule; involved in synthesis of the hnk-1 (natural killer t-cell) epitope expressed on neuronal or immune cells |
| 03/21/2000 | US6040146 Detection of mammary tumor virus-like sequences in human breast cancer |
| 03/16/2000 | WO2000014217A2 G-motif oligonucleotides and uses thereof |
| 03/16/2000 | WO2000014102A1 Photoresponsive nucleosides and phosphoramidites |
| 03/16/2000 | WO2000014101A1 Pteridine nucleotide analogs |
| 03/16/2000 | WO2000014098A1 Methods for the preparation of conjugated oligomers |
| 03/16/2000 | WO2000014048A1 Oligonucleotide protecting groups |